NCT07659990 RISS Versus SPSIP Block in Modified Radical Mastectomy
| NCT ID | NCT07659990 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ferit Yetik |
| Condition | Postoperative Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2026-06-19 |
| Primary Completion | 2026-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2026-06-19 with a primary completion date of 2026-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective randomized double-blind controlled trial aims to compare the postoperative analgesic efficacy and dermatomal spread of rhomboid intercostal-subserratus plane (RISS) block and serratus posterior superior intercostal plane (SPSIP) block in patients undergoing modified radical mastectomy. Postoperative pain scores, opioid consumption, rescue analgesic requirements, block-related complications, and quality of recovery outcomes will be evaluated.
Eligibility Criteria
Inclusion Criteria: * Female patients aged 18-75 years * ASA physical status I-III * Scheduled for elective unilateral modified radical mastectomy with axillary dissection under general anesthesia * Provision of written informed consent Exclusion Criteria: * Anticoagulant therapy * Bleeding diathesis * Known allergy to local anesthetics or opioids * Infection at the block application site or previous surgery in the block area * Cognitive impairment preventing NRS assessment * Pregnancy or lactation * Chronic opioid use * Severe hepatic or renal failure * Refusal to participate in the study * Technical inability to perform the block or failed block
Contact & Investigator
Mürsel Ekinci, MD
PRINCIPAL INVESTIGATOR
Bursa City Hospital
Frequently Asked Questions
Who can join the NCT07659990 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 75 Years, studying Postoperative Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07659990 currently recruiting?
Yes, NCT07659990 is actively recruiting participants. Contact the research team at dryusufalan@gmail.com for enrollment information.
Where is the NCT07659990 trial being conducted?
This trial is being conducted at Bursa, Turkey (Türkiye).
Who is sponsoring the NCT07659990 clinical trial?
NCT07659990 is sponsored by Ferit Yetik. The principal investigator is Mürsel Ekinci, MD at Bursa City Hospital. The trial plans to enroll 80 participants.